Search
for
Sort by
Research 91–120 of 293
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- Advancements in non-laser energy-based devices in trichology: A comprehensive review
- 55-Year-Old Female with Alopecia of the Scalp and Body After Chemotherapy
- WNT Signaling in Disease
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- XMU-MP-1 induces growth arrest in a model human mini-organ and antagonises cell cycle-dependent paclitaxel cytotoxicity
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- DPP-4 inhibition with linagliptin ameliorates the progression of premature aging in klotho−/− mice
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- Chemotoxicity in Carcinoma Breast Patients - Its Incidence and Trends in Severity - An Observational Study
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Periungual lesions secondary to chemotherapy with docetaxel
- Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Innovations for cost-effective and eco-friendly solutions to combat chemotherapy-induced alopecia: a narrative systematic review
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study
- Efficacy of Scalp Cooling combined with DHL-HisZnNa Lotion in the Prevention of Chemotherapy-Induced Alopecia in Patients with Breast Cancer
- Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose